BRIEF published on 05/14/2025 at 22:20, 1 year 5 months ago Bausch Health annonce les résultats des élections et les approbations lors de son assemblée annuelle 2025 Bausch Santé Vote Des Actionnaires Élection Du Directeur Assemblée Annuelle Approbation De L'indemnisation
BRIEF published on 05/14/2025 at 22:20, 1 year 5 months ago Bausch Health Announces Election Results and Approvals at 2025 Annual Meeting Bausch Health Annual Meeting Shareholder Vote Director Election Compensation Approval
PRESS RELEASE published on 05/14/2025 at 22:15, 1 year 5 months ago Bausch Health Announces 2025 Annual Meeting of Shareholder Results Bausch Health Companies Inc. announces election of 10 directors at 2025 annual meeting of shareholders and various approvals and appointments Shareholders Bausch Health Companies Inc. Compensation Annual Meeting Election Of Directors
BRIEF published on 05/06/2025 at 14:05, 1 year 6 months ago Xifaxan Reduces Risk of 30-Day Rehospitalization After OHE XIFAXAN Chronic Liver Disease OHE Rehospitalization Claims-Based Analysis Lactulose
BRIEF published on 05/06/2025 at 14:05, 1 year 6 months ago Xifaxan réduit le risque de réhospitalisation dans les 30 jours suivant une OHE XIFAXAN Maladie Chronique Du Foie Lactulose Réhospitalisation OHE Analyse Basée Sur Les Réclamations
PRESS RELEASE published on 05/06/2025 at 14:00, 1 year 6 months ago Xifaxan(R) (rifaximin) Treatment Following Overt Hepatic Encephalopathy (OHE) Hospitalization Associated with Reduced Risk of 30-Day OHE Rehospitalization New analysis shows Xifaxan efficacy in reducing OHE rehospitalizations regardless of prior treatment. Data presented at DDW 2025 XIFAXAN Bausch Health Gastroenterology OHE Rehospitalizations
BRIEF published on 04/30/2025 at 22:10, 1 year 6 months ago Bausch Health Reports First-Quarter 2025 Results Financial Results EBITDA Revenue Growth Bausch Health First Quarter 2025
BRIEF published on 04/30/2025 at 22:10, 1 year 6 months ago Bausch Health publie ses résultats du premier trimestre 2025 Résultats Financiers EBITDA Croissance Des Revenus Bausch Santé Premier Trimestre 2025
PRESS RELEASE published on 04/30/2025 at 22:05, 1 year 6 months ago Bausch Health Announces First Quarter 2025 Results Bausch Health Companies Inc. reports strong first quarter 2025 financial results with revenue growth, successful refinancing, and favorable court ruling. Company remains focused on profitable growth and shareholder value Financial Results Revenue Growth Shareholder Value Bausch Health First Quarter 2025
BRIEF published on 04/29/2025 at 14:05, 1 year 6 months ago Bausch Health Secures Health Canada Approval for Thermage FLX Thermage FLX Bausch Health Health Canada Aesthetic Technology Skin Tightening
Published on 11/11/2026 at 10:30, 1 hour 33 minutes ago Temas Engages Arcstone Canada for Capital Markets Advisory and Investor-Communications Services
Published on 11/11/2026 at 03:30, 8 hours 33 minutes ago CoTec Holdings Corp. Files Third Quarter Financial Statements and MD&A and Provides Market Commentary
Published on 11/11/2026 at 00:40, 11 hours 23 minutes ago Upgraded Tunkillia MRE Validates Optimised Scoping Study
Published on 11/10/2026 at 23:30, 12 hours 33 minutes ago CCL Industries Announces 2026 Third Quarter Results
Published on 11/10/2026 at 23:00, 13 hours 3 minutes ago Vanta Announces Appointment of Chief Financial Officer and Corporate Secretary
Published on 11/11/2026 at 11:46, 17 minutes ago ABO Energy GmbH & Co. KGaA intends to notify a Restructuring Project under the StaRUG
Published on 11/11/2026 at 11:18, 45 minutes ago Original-Research: Cantourage Group SE (von First Berlin Equity Research GmbH): Kaufen
Published on 11/11/2026 at 11:11, 52 minutes ago EQS-Adhoc: ABO Energy GmbH & Co. KGaA intends to notify a Restructuring Project under the StaRUG
Published on 11/11/2026 at 10:10, 1 hour 53 minutes ago EQS-Adhoc: Hapag-Lloyd further raises its earnings outlook for the current financial year
Published on 11/11/2026 at 10:00, 2 hours 3 minutes ago GBC AG and Apaton Finance invite investors to the Zefiro Investor Day on November 19, 2026
Published on 11/10/2026 at 18:00, 18 hours 3 minutes ago Déclaration du nombre total des droits de vote et du nombre d’actions au 31 octobre 2026
Published on 11/10/2026 at 17:45, 18 hours 18 minutes ago Damartex / Descriptif du programme de rachat d'actions
Published on 11/10/2026 at 17:35, 18 hours 28 minutes ago ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 octobre 2026
Published on 11/10/2026 at 17:31, 18 hours 31 minutes ago CNP Assurances SA annonce le succès de l’émission d’une obligation subordonnée Tier 2 de 500 M€.
